Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Kenneth A Follett, Richard L. Boortz-Marx, James M. Drake, Stuart DuPen, Steven J. Schneider, Michael S. Turner, Robert J. Coffey

Research output: Contribution to journalReview article

117 Citations (Scopus)

Abstract

Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

Original languageEnglish (US)
Pages (from-to)1582-1594
Number of pages13
JournalAnesthesiology
Volume100
Issue number6
DOIs
StatePublished - Jun 1 2004

Fingerprint

Spinal Cord Stimulation
Equipment and Supplies
Infection
Cerebrospinal Fluid Shunts
Pharmaceutical Preparations
Surgical Wound Infection
Guidelines
Anti-Bacterial Agents
Incidence
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Follett, K. A., Boortz-Marx, R. L., Drake, J. M., DuPen, S., Schneider, S. J., Turner, M. S., & Coffey, R. J. (2004). Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology, 100(6), 1582-1594. https://doi.org/10.1097/00000542-200406000-00034

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. / Follett, Kenneth A; Boortz-Marx, Richard L.; Drake, James M.; DuPen, Stuart; Schneider, Steven J.; Turner, Michael S.; Coffey, Robert J.

In: Anesthesiology, Vol. 100, No. 6, 01.06.2004, p. 1582-1594.

Research output: Contribution to journalReview article

Follett, KA, Boortz-Marx, RL, Drake, JM, DuPen, S, Schneider, SJ, Turner, MS & Coffey, RJ 2004, 'Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections', Anesthesiology, vol. 100, no. 6, pp. 1582-1594. https://doi.org/10.1097/00000542-200406000-00034
Follett, Kenneth A ; Boortz-Marx, Richard L. ; Drake, James M. ; DuPen, Stuart ; Schneider, Steven J. ; Turner, Michael S. ; Coffey, Robert J. / Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. In: Anesthesiology. 2004 ; Vol. 100, No. 6. pp. 1582-1594.
@article{ab7ee5a1be6c4bbbb297934674f0503e,
title = "Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections",
abstract = "Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.",
author = "Follett, {Kenneth A} and Boortz-Marx, {Richard L.} and Drake, {James M.} and Stuart DuPen and Schneider, {Steven J.} and Turner, {Michael S.} and Coffey, {Robert J.}",
year = "2004",
month = "6",
day = "1",
doi = "10.1097/00000542-200406000-00034",
language = "English (US)",
volume = "100",
pages = "1582--1594",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

AU - Follett, Kenneth A

AU - Boortz-Marx, Richard L.

AU - Drake, James M.

AU - DuPen, Stuart

AU - Schneider, Steven J.

AU - Turner, Michael S.

AU - Coffey, Robert J.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

AB - Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

UR - http://www.scopus.com/inward/record.url?scp=2542444294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542444294&partnerID=8YFLogxK

U2 - 10.1097/00000542-200406000-00034

DO - 10.1097/00000542-200406000-00034

M3 - Review article

VL - 100

SP - 1582

EP - 1594

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 6

ER -